BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
2
Ehab Mohammed. Improved liver function after high dose intravenous vitamin C and Helxior SC injections in a patient with hepatocellular carcinoma progressed after chemotherapy and radiationJournal of Cancer Prevention & Current Research 2018; 9(4) doi: 10.15406/jcpcr.2018.09.00350
3
Yi-Hsuan Chuang, Hsin-You Ou, Chun-Yen Yu, Chao-Long Chen, Ching-Chun Weng, Leo Leung-Chit Tsang, Hsien-Wen Hsu, Wei-Xiong Lim, Tung-Liang Huang, Yu-Fan Cheng. Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantationCancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0264-y
4
Onur Yaprak, Sencan Acar, Gokhan Ertugrul, Murat Dayangac. Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantationWorld Journal of Gastrointestinal Oncology 2018; 10(10): 336-343 doi: 10.4251/wjgo.v10.i10.336
5
Aloysious D. Aravinthan, Silvio G. Bruni, Adam C. Doyle, Hla-Hla Thein, Nicolas Goldaracena, Assaf Issachar, Leslie B. Lilly, Nazia Selzner, Mamatha Bhat, Boraiah Sreeharsha, Markus Selzner, Anand Ghanekar, Mark S. Cattral, Ian D. McGilvray, Paul D. Greig, Eberhard L. Renner, David R. Grant, Gonzalo Sapisochin. Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular CarcinomaAnnals of Surgical Oncology 2017; 24(7): 1843 doi: 10.1245/s10434-017-5789-3
6
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
7
Tyler A. Sandow, Stephen E. Arndt, Abeer A. Albar, Daniel A. DeVun, David S. Kirsch, Juan M. Gimenez, Humberto E. Bohorquez, Patrick J. Gilbert, Paul T. Thevenot, Kelley G. Nunez, Gretchen A. Galliano, Ari J. Cohen, Dennis Kay, Paul M. Gulotta. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant CohortRadiology 2018; 286(3): 1072 doi: 10.1148/radiol.2017170731
8
Roberto Santambrogio, Claudia Cigala, Matteo Barabino, Marco Maggioni, Giovanna Scifo, Savino Bruno, Emanuela Bertolini, Enrico Opocher, Gaetano Bulfamante. Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behaviour: Prospective comparison with pathologyLiver International 2018; 38(2): 312 doi: 10.1111/liv.13524
9
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular CarcinomaDigestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
10
Hae Won Lee, Kyung-Suk Suh. Liver transplantation for advanced hepatocellular carcinomaClinical and Molecular Hepatology 2016; 22(3): 309 doi: 10.3350/cmh.2016.0042
11
Joseph DiNorcia, Sander S. Florman, Brandy Haydel, Parissa Tabrizian, Richard M. Ruiz, Goran B. Klintmalm, Srinath Senguttuvan, David D. Lee, C. Burcin Taner, Elizabeth C. Verna, Karim J. Halazun, Maarouf Hoteit, Matthew H. Levine, William C. Chapman, Neeta Vachharajani, Federico Aucejo, Mindie H. Nguyen, Marc L. Melcher, Amit D. Tevar, Abhinav Humar, Constance Mobley, Mark Ghobrial, Trevor L. Nydam, Beth Amundsen, James F. Markmann, Jennifer Berumen, Alan W. Hemming, Alan N. Langnas, Carol A. Carney, Debra L. Sudan, Johnny C. Hong, Joohyun Kim, Michael A. Zimmerman, Abbas Rana, Michael L. Kueht, Christopher M. Jones, Thomas M. Fishbein, Daniela Markovic, Ronald W. Busuttil, Vatche G. Agopian. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery 2020; 271(4): 616 doi: 10.1097/SLA.0000000000003253
12
Julia Herreras, Tommaso Di Maira, Carmen Vinaixa, Fernando San Juan, Ángel Rubín, Marina Berenguer. Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver TransplantationTransplantation Direct 2019; 5(10): e487 doi: 10.1097/TXD.0000000000000934
13
Dong Ik Cha, Kyung Mi Jang, Seong Hyun Kim, Young Kon Kim, Honsoul Kim, Soo Hyun Ahn. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma PatientsKorean Journal of Radiology 2020; 21(4): 402 doi: 10.3348/kjr.2019.0538
14
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approachesNature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
15
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinomaJournal of Surgical Oncology 2019; 120(7): 1126 doi: 10.1002/jso.25721
16
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular CarcinomaJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
17
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
18
Kun Zhu, Lili Zhou, Manshu Zou, Shuangcheng Ning, Shulan Liu, Yilin Zhou, Ke Du, Xiaoqing Zhang, Xinhua Xia. 18-GA-Suc Modified Liposome Loading Cantharidin for Augmenting Hepatic Specificity: Preparation, Characterization, Antitumor Effects, and Liver-Targeting EfficiencyJournal of Pharmaceutical Sciences 2020; 109(6): 2038 doi: 10.1016/j.xphs.2020.03.001
19
Jin Wang, Qungang Shan, Yong Liu, Hao Yang, Sichi Kuang, Bingjun He, Yao Zhang, Jingbiao Chen, Tianhui Zhang, Kevin J. Glaser, Cairong Zhu, Jun Chen, Meng Yin, Sudhakar K. Venkatesh, Richard L. Ehman. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor RecurrenceJournal of Magnetic Resonance Imaging 2019; 49(3): 719 doi: 10.1002/jmri.26250
20
Louis Leong-Liung Ling, Chien-Chin Hsu, Chee-Chien Yong, Ahmed M. Elsarawy, Yi-Chia Chan, Chih-Chi Wang, Wei-Feng Li, Ting-Lung Lin, Fang-Ying Kuo, Yu-Fan Cheng, Li-Man Lin, Chao-Long Chen, Chih-Che Lin. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort studyInternational Journal of Surgery 2019; 69: 124 doi: 10.1016/j.ijsu.2019.07.035
21
Sunyoung Lee, Kyoung Won Kim, Woo Kyoung Jeong, Myeong-Jin Kim, Gi Hong Choi, Jin Sub Choi, Gi-Won Song, Sung-Gyu Lee. Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantationEuropean Radiology 2020; 30(2): 987 doi: 10.1007/s00330-019-06424-0
22
Jiong‐Ze Fang, Li Xiang, Yang‐Ke Hu, Yong Yang, Hong‐Da Zhu, Cai‐De Lu. Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: Salvage liver transplantation or rehepatectomy?Clinical Transplantation 2020; 34(5) doi: 10.1111/ctr.13831